Personalis, Inc. (PSNL) Form 10-K Annual Reports
Personalis, Inc. (PSNL) is a publicly traded company on the Nasdaq, categorized under SIC 8071 (Services-Medical Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PSNL
CIK: 1527753
Exchange: Nasdaq
SIC 8071: Services-Medical Laboratories
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerJeremy Wotton
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 425 | 2026-10-06 | — | 425 | 0001193125-26-415562 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-02 | 8-K | 0001193125-26-415547 | View SEC Doc Filr Page |
| SC 13E3/A | 2026-10-02 | — | SC 13E3/A | 0001193125-26-412568 | View SEC Doc Filr Page |
| CT ORDER | 2026-10-02 | — | CT ORDER Filing | 9999999997-26-001576 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 Filing | 0001915342-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 Filing | 0001779787-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 Filing | 0001449535-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 Filing | 0001401786-26-000009 | View SEC Doc Filr Page |
| 425 | 2026-09-15 | — | 425 | 0001193125-26-392159 | View SEC Doc Filr Page |
| SC 13E3 | 2026-08-31 | — | SC 13E3 | 0001193125-26-377066 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-20 | 8-K | 0001193125-26-359300 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-350856 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003485 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001193125-26-332817 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001193125-26-332748 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0002012383-26-002853 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-21 | — | SCHEDULE 13D/A Filing | 0001193125-26-310289 | View SEC Doc Filr Page |
| 425 | 2026-07-20 | — | 425 | 0001193125-26-309106 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-20 | 8-K | 0001193125-26-309101 | View SEC Doc Filr Page |
| 425 | 2026-07-20 | — | 425 | 0001193125-26-309096 | View SEC Doc Filr Page |
| 425 | 2026-07-20 | — | 425 | 0001193125-26-309093 | View SEC Doc Filr Page |
| 425 | 2026-07-20 | — | 425 | 0001193125-26-309090 | View SEC Doc Filr Page |
| 425 | 2026-07-20 | — | 425 | 0001193125-26-309081 | View SEC Doc Filr Page |
| 425 | 2026-07-20 | — | 425 | 0001193125-26-308500 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-20 | 8-K | 0001193125-26-308488 | View SEC Doc Filr Page |